CICLOPIROX TENTACLE is a cardiopulmonary resuscitation (CPR) device that uses artificial intelligence to automatically assess and treat patients.
The company, founded in 2015, has raised $1.7 billion in funding, including a $250 million Series A round in June.
The device uses deep learning and artificial intelligence, and it’s been shown to treat a variety of conditions, including pneumonia, hypertension, multiple sclerosis, and other heart disorders.
“We have seen incredible progress in this space with CICLPOR, and we are thrilled to be a part of this exciting new field of healthcare technology,” CICLO founder and CEO Jia Xu said in a statement.
“The team at CICLL is driven to create the next generation of technology to help patients, healthcare professionals, and healthcare organizations achieve their health care goals.”